SLAMF8 and Epstein-Barr virus infection: On the basis that SLAMF8 tagged the coexpression signature that was able to cluster the GI cancer tissues irrespective of EBV infection, we tested whether high‐expression SLAMF8 in GI cancer had an activated phenotype for antitumor immune response.